Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 17 March 2000:
Vol. 287. no. 5460, pp. 1952 - 1953
DOI: 10.1126/science.287.5460.1952
Prev | Table of Contents | Next

News

When Pharma Merges, R&D Is the Dowry

Bruce Agnew

Pharmaceutical companies' continuing quest to get bigger is not just megalomania. Although no company has even a double-digit slice of the global prescription drug market, each must have enough market share and product lines to maintain a significant presence in the United States, Europe, and Japan. Staying on top also requires doing more and better research, both to take advantage of new opportunities and to cover the continuing rise in the cost of developing new drugs.

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)